Navigation Links
Roper Industries Announces Record Third Quarter Results
Date:10/25/2007

200,127 47.0% 164,943 47.1%

Total $772,322 50.1% $625,530 50.6%

Operating profit*:

Industrial Technology $120,721 25.3% $92,489 23.0%

Energy Systems & Controls 81,579 22.6% 59,077 25.3%

Scientific & Industrial Imaging 53,453 19.3% 52,703 21.1%

RF Technology 90,669 21.3% 62,368 17.8%

Total $346,422 22.5% $266,637 21.6%

Net Orders:

Industrial Technology $479,100 $436,595

Energy Systems & Controls 376,611 231,350

Scientific & Industrial Imaging 278,212 245,140

RF Technology 424,827 348,614

Total $1,558,750 $1,261,699

* Operating profit is before unallocated corporate general and

administrative expenses. Such expenses were $11,567 and $8,511 for

the three months ended September 30, 2007 and 2006, respectively, and

$31,877 and $26,249 for the nine months ended September 30, 2007

and 2006, respectively.

Roper Industries, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows (unaudited)

(Amounts in thousands)

Nine months ended

September 30,

2007 2006

Net earnings $177,803 $136,593

Depreciation 23,560 21,632

Amortization 46,643 38,694

Other, net (21,035) (43,386)

Cash provided by operatin
'/>"/>

SOURCE Roper Industries, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Proper Diet Can Counter Macular Degeneration
2. FDA issues warning for Droperidol
3. Tetanus causing toxin has therapeutic properties
4. Compounds Found In The Vegetable Broccoli Could Have Anti-Cancer Properties
5. Geriatric Patients With Chronic Kidney Disease May Not Be Treated Properly
6. The effects of Curcumin: a natural pigment in turmeric explored for its anti-cancer properties
7. Stem Cells, Tumor Cells Share Similar Properties: Scope For Treatment and Prevention?
8. Fruits And Vegetables Have Arthritis Risk Reducing Property
9. Proper Validation of Generic Drugs Could Save Millions of AIDS Patients
10. Proper Treatment of Hypothyroidism Found To Prevent Heart Diseases
11. Improperly Placed And Heavy Backpacks Lead To Back Pain In School Children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)...BEND, Ind., Jan. 8 Press Ganey Ass...ientFlow Technology (PatientFlow), a,leading prov... for hospitals.,The Boston-based company speciali...strategic solutions for patient flow issues such a...umped or delayed surgeries, and lack of,available...
(Date:1/7/2009)...CH, Fla., Jan. 7 Non-profits Medical Tourism Asso...Monterrey Health Care City ( www.monterreyciudad...te the 1st Latin America Medical Tourism and Healt...09 in Monterrey, Mexico at the Intercontinental Pr...stinations of medical tourism in Latin America, ha...
(Date:1/7/2009)...., Jan. 7 Insulet Corporation (Nasdaq: PODD ), ...od(R) Insulin Management System, today announced t.... Morgan Healthcare Conference. Management is sche...0 a.m. PST on January 14, 2009 at The Westin St. F...rence presentation, material information concernin...
(Date:1/7/2009)..., Tenn., Jan. 7 Ambulatory Services of America,In...a, LLC, its seventh,radiation oncology joint ventu...g Gulf Coast Cancer Center - Gulf Shores, P.C., Mo...abama Radiation Oncology, P.C., and ASA,s,subsidia...ROSA of South,Alabama will own and operate four ra...
Breaking Medicine News(10 mins):Health News:Press Ganey Acquires PatientFlow Technology 2Health News:The Non-Profits Medical Tourism Association (MTA), Monterrey Health Care City (MHCC) Have Partnered Together to Create the 1st Latin America Medical Tourism and Health Tourism Congress Which Occurs April 27-29th, 2009 in Monterrey, Mexico at the Intercont 2Health News:The Non-Profits Medical Tourism Association (MTA), Monterrey Health Care City (MHCC) Have Partnered Together to Create the 1st Latin America Medical Tourism and Health Tourism Congress Which Occurs April 27-29th, 2009 in Monterrey, Mexico at the Intercont 3Health News:The Non-Profits Medical Tourism Association (MTA), Monterrey Health Care City (MHCC) Have Partnered Together to Create the 1st Latin America Medical Tourism and Health Tourism Congress Which Occurs April 27-29th, 2009 in Monterrey, Mexico at the Intercont 4Health News:Ambulatory Services of America, Inc. Announces Joint Venture with Gulf Coast Cancer Centers 2
...sts at the University of Canberra claim that they ...viour of children. // Positive parenting program w... master unit, with an intention to make parenting ... anxiety levels in parents by altering children’s ...
...tending the 16th International AIDS Conference in ...ica are at risk of plunging into a silent epidemic...Middle East and North Africa carry the virus that ...s the lowest rate of HIV infection in the world ac...
...nsplant at TG Hospital gave a B.C. youngster a bow...rince George, B.C. was told to prepare// for the d...o prepare and to accept, but I still wasn't on tha...recovering following a high-risk, four-organ trans...
...o improve the management of the Queensland's healt... has called for a doctor to head the system//. Dr ... that Dr Bruce Flegg, the new Liberal leader, coul...iling system and added that Peter Beattie Governme...
Other Medicine News:Health News:Parenting skills to manage bad behaviour 2Health News:Risk of Silent AIDS epidemic in Middle East and North Africa 2Health News:Rare Transplant Gives B.C Youngster 4 New Organs 2Health News:Rare Transplant Gives B.C Youngster 4 New Organs 3
(Date:1/5/2009)...lene Pharmaceuticals announced today that it has i...protein kinase inhibitor, CX-4945, in patients wit...ultiple myeloma. The primary endpoints of the oral..., tolerance and PK properties of CX-4945 and to se...addition, multiple mechanism-related pharmacodynam...
(Date:12/30/2008)...wswire/ -- The Coalition for 21st Century Medicine...nentech, Inc. on December 5, 2008, seeking to rest...ic tests to physicians and patients. The request ...rm patient care and rests on flawed scientific and... to encourage the research, development, and comme...
(Date:12/27/2008)...lence, offers to ease cloning costs for Clonaid cl...27 Six years to the day...ld, Dr. Brigitte Boisselier, head of the company t...babies cloned by her company are growing up health...lies, privacy. , , "We,ve helped almost 100 fam...
(Date:12/17/2008)...-- PEAK Surgical, Inc., a medical,device company ...based on a,proprietary technology, announced toda...) has granted the company 510(k) clearance to mark...gulation of soft tissue during,plastic and recons...,orthopedic, arthroscopic, spinal and neurologica...
Breaking Medicine Technology:Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 2Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 3Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 4'We're Ready to Prove It!' 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 4New Method Better Predictor of In Vitro Fertilization Success 23077 1New Method Better Predictor of In Vitro Fertilization Success 23077 2Death Rates for HIV Patients Decrease Dramatically 23075 1Death Rates for HIV Patients Decrease Dramatically 23075 2Death Rates for HIV Patients Decrease Dramatically 23075 3Penn animal study identifies new DNA weapon against avian flu 23073 1Penn animal study identifies new DNA weapon against avian flu 23073 2Penn animal study identifies new DNA weapon against avian flu 23073 3Fungi the cause of many outbreaks of disease but mostly ignored 3851 1Fungi the cause of many outbreaks of disease but mostly ignored 3851 2Fungi the cause of many outbreaks of disease but mostly ignored 3851 3
...erland, April 25, 2007 - Basilea Pharmaceutica Ltd...s showing that,patients with severe chronic hand e...oin. In two previous randomized clinical,trials, a...severe,chronic hand eczema in patients refractory ...ated that patients responsive to initial,treatment...
....--(BUSINESS WIRE)--Apr 25, 2007 - OSI,Pharmaceuti...ults,published yesterday in the Journal of Clinica... to gemcitabine chemotherapy,significantly improve... to patients with advanced pancreatic cancer. Data... Institute of Canada (NCIC),formed the basis of b...
Other Medicine Technology:Basilea Reports Positive Re-treatment Results from a Second Phase,III Trial of Alitretinoin for Patients with Severe Chronic Hand,Eczema 2Basilea Reports Positive Re-treatment Results from a Second Phase,III Trial of Alitretinoin for Patients with Severe Chronic Hand,Eczema 3Basilea Reports Positive Re-treatment Results from a Second Phase,III Trial of Alitretinoin for Patients with Severe Chronic Hand,Eczema 4Basilea Reports Positive Re-treatment Results from a Second Phase,III Trial of Alitretinoin for Patients with Severe Chronic Hand,Eczema 5OSI Pharmaceuticals Announces Pivotal Phase III Tarceva Study,Published in the Journal of Clinical Oncology Showed Survival,Improvement in Patients with Pancreatic Cancer 2OSI Pharmaceuticals Announces Pivotal Phase III Tarceva Study,Published in the Journal of Clinical Oncology Showed Survival,Improvement in Patients with Pancreatic Cancer 3OSI Pharmaceuticals Announces Pivotal Phase III Tarceva Study,Published in the Journal of Clinical Oncology Showed Survival,Improvement in Patients with Pancreatic Cancer 4
STABIBAG Hydrophilic Acrylic Lens.
XL STABI Hydrophilic Acrylic Lens.
FZ60 : the 1st monobloc hard & soft IOL. Thanks to an exclusive and patented process : the selective polymerisation, IOLTECH designed the first single piece rigid & soft IOL : the FZ60. This technolo
XL OCTO Hydrophilic Acrylic Lens.
Medicine Products: